STOCK TITAN
  1. Home
  2. News
  3. A

Agilent Technologies Inc. - A STOCK NEWS

Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.

Agilent Technologies Inc., originally spun out of Hewlett-Packard in 1999, has evolved into a leading firm in the life sciences and diagnostics sector. The company specializes in creating advanced measurement technologies that serve a vast range of customers across various industries.

The company's core business revolves around three main segments: life science and applied tools, cross lab (which includes consumables and services related to life sciences and applied tools), and diagnostics and genomics. These segments collectively cater to a broad spectrum of markets, including biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government-related organizations.

Agilent's geographical reach is extensive, with significant operations in the U.S. and China. The company is committed to addressing global trends impacting human health and the environment and continuously anticipates future scientific needs.

Agilent provides comprehensive laboratory solutions that enhance the efficiency of laboratories, from sample preparation to data interpretation and management. Their instruments, software, services, and consumables are designed to meet the most complex laboratory demands, empowering scientists and researchers worldwide to make impactful discoveries and improvements in various fields.

Recent achievements include advancements in biopharmaceutical technology, collaborations with leading research institutions, and the launch of state-of-the-art diagnostic tools. The company also emphasizes sustainable practices and innovations aimed at improving human health and environmental outcomes.

News

Agilent Presents Solutions Innovation Research Awards to Drexel University and Prairie View A&M University Researchers

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) awards Distinguished Professors Michel Barsoum, Yury Gogotsi, and Ananda Amarasekara for their innovative research in advanced materials to enhance energy storage technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.26%
Tags
none
-
News

Agilent Reports First-Quarter Fiscal Year 2024 Financial Results

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) reported Q1 revenue of $1.66 billion, down 5.6% reported and 6.4% core from last year. GAAP net income was $348 million, EPS $1.18, and non-GAAP net income $380 million, EPS $1.29. Full-year revenue outlook maintained at $6.710 - $6.810 billion with earnings guidance of $5.44 - $5.55 per share for FY 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.36%
Tags
earnings
-
News

Agilent Announces Cash Dividend of 23.6 Cents per Share

Rhea-AI Summary
Agilent Technologies Inc. (A) declares a quarterly dividend of 23.6 cents per share of common stock, payable on April 24, 2024, to shareholders of record as of April 2, 2024, subject to board approval.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
dividends
News

Agilent CEO Mike McMullen to Retire; Agilent CrossLab Group President Padraig McDonnell Named CEO-Elect

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) announces Padraig McDonnell as CEO-elect and COO, succeeding current CEO Mike McMullen. McDonnell, with nearly 40 years of experience, will take over on May 1, with McMullen retiring on Oct. 31. The transition reflects Agilent's strong leadership and succession planning.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
none
-
News

Agilent Ranked Among Top 50 Most Just Companies in America

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has been recognized as one of the Most JUST Companies in America by Just Capital and CNBC for the sixth consecutive year. The company has consistently ranked in the top 50, showcasing its commitment to business issues important to the public, such as fair wages, job creation, and stakeholder accountability. Agilent's focus on ESG programs and community prosperity has earned it this prestigious recognition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
none
-
News

Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Development Products

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has received two prestigious awards from SelectScience for Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year. The awards highlight Agilent's commitment to innovation and excellence in drug discovery and development. The Agilent xCELLigence RTCA HT-BioTek BioSpa 8 - Screening Model won the Best New Drug Discovery & Development Product of 2023. The Drug Discovery & Development Webinar of the Year was co-produced between Agilent and Dr. Agapitos Patakas, Chief Scientific Officer, Antibody Analytics. The awards were presented at the 2024 SLAS International Conference and Exhibition in Boston, Massachusetts, and recognize innovative and effective technologies advancing drug discovery and development in 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
none
News

Agilent to Participate in TD Cowen Health Care Conference

Rhea-AI Summary
Agilent Technologies Inc. (A) CFO Bob McMahon to participate in fireside chat at the 44th Annual TD Cowen Health Care Conference. The event will take place in Boston, Massachusetts, on March 4, at 2:50 p.m. EST. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
conferences
-
News

Agilent Announces Collaboration with Incyte to Develop Advanced Companion Diagnostics in Hematology and Oncology

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has announced a partnership with Incyte to develop companion diagnostics (CDx) for Incyte’s hematology and oncology portfolio. The companion diagnostics market is expected to grow to nearly US $14B by 2030, driven by the increasing use of these tests to inform treatment decisions for a variety of cancers and chronic diseases. The collaboration will allow Agilent to expand its CDx portfolio with novel biomarkers, while leveraging Incyte’s expertise in IVD assay development and global regulatory approvals. The partnership aims to expedite the development of precision medicine products, potentially improving patient health outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
none
-
News

Agilent to Announce First-Quarter Fiscal Year 2024 Financial Results Feb. 27

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) is set to release its financial results for the first quarter of fiscal year 2024, with the conference call scheduled to discuss the results. The call will be available for 90 days on the company's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.08%
Tags
earnings
News

Agilent Announces New ProteoAnalyzer System

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has announced the release of a new automated parallel capillary electrophoresis system for protein analysis, the Agilent ProteoAnalyzer system. The new platform simplifies and improves the efficiency of analyzing complex protein mixtures, benefiting diverse sectors from pharma to academia. The system brings added efficiency, versatility, and reliability, particularly in protein QC workflows. It can analyze different sizes and types of proteins in a single run and consistently deliver accurate results, reducing the need for time-consuming and costly reanalysis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.01%
Tags
none

FAQ

What is the current stock price of Agilent Technologies (A)?

The current stock price of Agilent Technologies (A) is $152.57 as of January 21, 2025.

What is the market cap of Agilent Technologies (A)?

The market cap of Agilent Technologies (A) is approximately 43.0B.

What does Agilent Technologies Inc. specialize in?

Agilent specializes in life sciences, diagnostics, and measurement technologies, providing advanced solutions and services for laboratories.

When was Agilent Technologies Inc. founded?

Agilent Technologies was spun out of Hewlett-Packard in 1999.

What are the main business segments of Agilent Technologies Inc.?

Agilent operates in three main segments: life science and applied tools, cross lab, and diagnostics and genomics.

Which industries does Agilent Technologies Inc. serve?

Agilent serves industries such as biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government organizations.

Where are Agilent Technologies Inc.'s main operations located?

Agilent's main operations are located in the U.S. and China.

What recent achievements has Agilent Technologies Inc. made?

Recent achievements include advancements in biopharmaceutical technology, collaborations with research institutions, and new diagnostic tools.

How does Agilent Technologies Inc. contribute to laboratory efficiency?

Agilent enhances laboratory efficiency through comprehensive solutions for sample preparation, data interpretation, and management.

What sustainable practices does Agilent Technologies Inc. emphasize?

Agilent focuses on innovations that improve human health and environmental outcomes, emphasizing sustainability in its practices.

Why do scientists and researchers trust Agilent Technologies Inc.?

Scientists and researchers trust Agilent for its reliable solutions that meet complex laboratory demands and enable significant insights.

What kind of global issues does Agilent Technologies Inc. address?

Agilent addresses global issues related to human health and the environment, anticipating future scientific needs.
Stock A logo
Agilent Technologies Inc.

NYSE:A

A Rankings

#311 Ranked by Market Cap
#1952 Ranked by Dividends

A Stock Data

43.00B
284.65M
Analytical Laboratory Instrument Manufacturing
Laboratory Analytical Instruments
Link
United States of America
SANTA CLARA